Prognostic implications of different cell cycle analysis models of flow cytometric DNA histograms of 1,301 breast cancer patients: Results from the Multicenter Morphometric Mammary Carcinoma Project (MMMCP)

International Journal of Cancer

Volumn 74, Issue 3, 1997, Pages 260-269

  Bergers, Elisabeth ^a   Baak, Jan P A ^a   Van Diest, Paul J ^a   Van Gorp, Leo H M ^a   Kwee, Wien S ^a   Los, Jan ^a   Peterse, Hans L ^a   Ruitenberg, Hans M ^a   Schapers, Rene F M ^a   Somsen, Johan G ^a   Van Beek, Mike W P M ^a   Bellot, Stanley M ^a   Fijnheer, Jaap ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; BREAST CANCER; CELL CYCLE S PHASE; CELL PROLIFERATION; COMPUTER PROGRAM; DIPLOIDY; FLOW CYTOMETRY; HISTOGRAM; HUMAN; HUMAN TISSUE; MORPHOMETRICS; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; S PHASE; SURVIVAL ANALYSIS;

EID: 8544264541     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970620)74:3<260::AID-IJC5>3.0.CO;2-X     Document Type: Article

References (25)

1. BAAK, J.P.A. and 13 OTHERS. The Multicenter Morphometric Mammary Carcinoma Project (MMMCP). A nationwide prospective study on reproducibility and prognostic power of routine quantitative assessments in the Netherlands. Pathol. Res. Pract., 185, 664-670 (1989).
2. BERGERS, E., MONTIRONI, R., VAN DIEST, P.J., PRETE, E. and BAAK, J.P.A., Inter-laboratory reproducibility of semi-automated cell cycle analysis of flow cytometric DNA-histograms obtained from fresh material of 1295 breast cancer cases. Hum. Pathol., 27, 553-560 (1996).
3. BERGERS, E., VAN DIEST, P.J. and BAAK, J.P.A., Reproducibility of semi-automated cell cycle analysis of flow cytometric DNA-histograms of fresh breast cancer material. Anal. Cell. Pathol., 8, 1-13 (1995).
4. BERGERS, E., VAN DIEST, P.J. and BAAK, J.P.A., Comparison of 5 cell cycle analysis models applied to 1494 flow cytometric DNA-histograms of fresh frozen breast cancer. Clin. Comm. Cytometry, (1997) (In press).
5. BOSARI, S., LEE, A.K.C., TAHAN, S.R., FIGONI, M.A.T., WILEY, B.D., HEATLEY, G.J. and SILVERMAN, M.L., DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma. Cancer. 70, 1943-1950 (1992).
6. DRESSLER, L.G., EUDEY, L., GRAY, R., TORMEY, D.C., MCGUIRE, L.W., GILCHRIST, K.W., CLARK, G.M., OSBORNE, C.K., MANSOUR, E.G. and ABELOFF, M.D., Prognostic potential of DNA flow cytometry measurements in node negative breast cancer patients: preliminary analysis of an intergroup study (INT0076). J. Cancer Inst. Monogr., 11, 167-172 (1992).
7. EWERS, S.B., ATTEWELL, R., BALDETORP, B., BORG, A., LANGSTRÖM, E. and KILLANDER, D., Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas. Breast Cancer Res. Treat., 20, 93-108 (1991).
8. FISHER, B., GUNDUZ, N., CONTANTINO, J., FISHER, E.R., REDMOND, C., MAMOUNAS, E.P. and SIDERITS, R., DNA flow cytometric analysis of primary operable breast cancer. Cancer, 68, 1465-1475 (1991).
9. JOENSUU, H., TOIKKANEN, S. and KLEMI, P.J., DNA Index and S-phase fraction and their combination as prognostic factors in operable ductal breast carcinoma. Cancer, 66, 331-340 (1990).
10. KALLIONIEMK O.P., HIETANEN, T., MATTILA, J., LEHTINEN, M., LAUSLAHTI, K. and KOIVULA, T., Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer. Europ. J. Cancer clin. Oncol., 23, 277-282 (1987).
11. KALLIONIEMI, O.P., VISAKORPI, T., HOLLI, K., HEIKKINEN, A., ISOLA, J. and KOIVULA, T., Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing. Cytometry, 12, 413-421 (1991).
12. KUTE, T.E., MUSS, H.V., COOPER, M.R., CASE, L.D., BUSE, D., STANLEY, V., GREGORY, B., GALLESHAW, J. and BOOHER, K., The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients. Cancer, 66, 1810-1816 (1990).
13. MERKEL, D.E., WINCHESTER, D.J., GOLDSCHMIDT, R.A., AUGUST, C.Z., WRUCK, D.M. and RADEMAKER, A.W., DNA flow cytometry and pathologic gradigs, as prognostic guides in axillary lymph node negative breast cancer. Cancer, 72, 1926-1932 (1993).
14. MUSS, H.B., KUTE, T.E., SMITH, L.R., BOOHER, C., LONG, R., KAMMIRE, L., GREGORY, B. and BROCKSCHMIDT, J.K., The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer. Cancer. 64, 1894-1900 (1989).
15. O'REILLY, S.M., CAMPLEJOHN, R.S., BARNES, D.M., MILLIS, R.R., ALLEN, D., RUBENS, R.D. and RICHARDS, M.A., DNA index, S-phase fraction, histological grade and prognosis in breast cancer. Brit. J. Cancer, 61, 671-674 (1990).
16. RABINOVITCH, P.S., Practical considerations for DNA content and cell cycle analysis. In: K.D. Bauer, R.E. Duque, T.V. Shankey (eds.), Clinical flow cytometry, pp. 117-142, Williams & Wilkins, Baltimore (1993).
17. RABINOVITCH, P.S., MultiCycle A.V., Advanced version. DNA content and cell cycle analysis software (Manual). Phoenix Flow Systems, San Diego (1994).
18. SHANKY, T.V., RABINOVITCH, P.S., BAGWELL, B., BAUER, K.D., DUQUE, R.E., MEDLEY, D.W., MAYALL, B.H. and WHEELESS, L., Guidelines for implementation of clinical DNA cytometry. Cytometry, 14, 472-477 (1993).
19. SIGURDSSON, H., BALDETORP, B., BORG, A., DALBERG, M., FERNO, M., KILLANDER, D. and OLSSON, H., Indicators of prognosis in node-negative breast cancer. New Engl. J. Med., 322, 1045-1053 (1990).
20. SIGURDSSON, H., BALDETORP, B., BORG, A., DALBERG, M., FERNO, M., KILLANDER, D., OLSSON, H. and RANSTAM, J., Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels. Brit. J. Cancer, 62, 786-790 (1990).
21. STAL, O., WINGREN, S., CARSTENSEN, J., RUTQVIST, L.E., SKOOG, L., KLINTENBERG, C. and NORDENSKJÖLD, B., Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer. Europ. J. Cancer clin. Oncol., 25, 301-309 (1989).
22. TOIKKANEN, S., JOENSUU, H. and KLEMI, P., The prognostic significance of nuclear DNA content in invasive breast cancer - a study with long-term follow-up. Brit. J. Cancer, 60, 693-700 (1989).
23. UYTERLINDE, A.M., BAAK, J.P.A., SCHIPPER, N.W., PETERSE, H., MATZE, E. and MEIJER, C.J.L., Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-up. Int. J. Cancer, 45, 1-7 (1990).
24. VINDELØV, L.L., CHRISTENSEN, I.J. and NISSES, N.I., A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry. 3, 322-327 (1989).
25. WITZIG, T.E., INGLE, J.N., CHA, S.S., SCHAID, D.J., TABERY, R.L., WOLD, E.W., GRANT, C., GONCHOROFF, N.J. and KATZMANN, J.A., DNA ploidy and the percentage of cell in S-phase as prognostic factors for women with lymph node negative breast cancer. Cancer, 74, 1752-1761 (1994).